GREGORY B BROWN Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for GREGORY B BROWN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of GREGORY B BROWN. GREGORY B BROWN is Director in CAMBREX CORP ($CBM) and Director in Caladrius Biosciences, Inc. ($NBS) and Director in OSCIENT PHARMACEUTICALS CORP ($GENE) and in Aquestive Therapeutics, Inc. ($AQST).
Latest Insider Trading Transactions of GREGORY B BROWN
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AQST, NBS, CBM, GENE
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 12 2021 | NBS | CALADRIUS BIOSCIEN ... | BROWN GREGORY B | Director | Grant | A | 0.00 | 37,735 | 0 | 83,610 | 45.9 K to 83.6 K (+82.26 %) |
| Jun 18 2020 | AQST | Aquestive Therapeu ... | BROWN GREGORY B | Option Exercise | A | 5.30 | 14,000 | 74,200 | 14,000 | ||
| Jan 14 2020 | NBS | CALADRIUS BIOSCIEN ... | BROWN GREGORY B | Director | Grant | A | 3.28 | 18,292 | 59,998 | 45,875 | 27.6 K to 45.9 K (+66.32 %) |
| Dec 05 2019 | CBM | CAMBREX CORP | BROWN GREGORY B | Director | Option Exercise | M | 40.06 | 2,766 | 110,806 | 0 | |
| Dec 05 2019 | CBM | CAMBREX CORP | BROWN GREGORY B | Director | Option Exercise | M | 53.70 | 1,980 | 106,326 | 0 | |
| Dec 05 2019 | CBM | CAMBREX CORP | BROWN GREGORY B | Director | Option Exercise | M | 44.23 | 360 | 15,921 | 0 | |
| Dec 05 2019 | CBM | CAMBREX CORP | BROWN GREGORY B | Director | Sell | S | 60.00 | 9,015 | 540,900 | 0 | 9 K to 0 (-100.00 %) |
| Dec 05 2019 | CBM | CAMBREX CORP | BROWN GREGORY B | Director | Buy | M | 40.06 | 2,766 | 110,806 | 9,015 | 6.2 K to 9 K (+44.26 %) |
| Dec 05 2019 | CBM | CAMBREX CORP | BROWN GREGORY B | Director | Buy | M | 53.70 | 1,980 | 106,326 | 6,249 | 4.3 K to 6.2 K (+46.38 %) |
| Dec 05 2019 | CBM | CAMBREX CORP | BROWN GREGORY B | Director | Buy | M | 44.23 | 360 | 15,921 | 4,269 | 3.9 K to 4.3 K (+9.21 %) |
| Jun 17 2019 | AQST | Aquestive Therapeu ... | BROWN GREGORY B | Option Exercise | A | 4.38 | 13,350 | 58,473 | 13,350 | ||
| Apr 25 2019 | CBM | CAMBREX CORP | BROWN GREGORY B | Director | Option Exercise | A | 40.06 | 2,766 | 110,806 | 2,766 | |
| Apr 25 2019 | CBM | CAMBREX CORP | BROWN GREGORY B | Director | Grant | A | 0.00 | 2,247 | 0 | 3,909 | 1.7 K to 3.9 K (+135.20 %) |
| Jan 16 2019 | NBS | CALADRIUS BIOSCIEN ... | BROWN GREGORY B | Director | Grant | A | 4.95 | 12,121 | 59,999 | 27,583 | 15.5 K to 27.6 K (+78.39 %) |
| Jan 10 2019 | NBS | CALADRIUS BIOSCIEN ... | BROWN GREGORY B | Director | Grant | A | 0.00 | 8,747 | 0 | 15,462 | 6.7 K to 15.5 K (+130.26 %) |
| Jul 26 2018 | AQST | Aquestive Therapeu ... | BROWN GREGORY B | Option Exercise | A | 15.00 | 26,700 | 400,500 | 26,700 | ||
| Apr 30 2018 | CBM | CAMBREX CORP | BROWN GREGORY B | Director | Option Exercise | A | 53.70 | 1,980 | 106,326 | 1,980 | |
| Apr 30 2018 | CBM | CAMBREX CORP | BROWN GREGORY B | Director | Grant | A | 0.00 | 1,397 | 0 | 1,662 | 265 to 1.7 K (+527.17 %) |
| Jan 10 2018 | NBS | CALADRIUS BIOSCIEN ... | BROWN GREGORY B | Director | Option Exercise | A | 0.00 | 8,747 | 0 | 8,747 | |
| Nov 02 2017 | CBM | CAMBREX CORP | BROWN GREGORY B | Director | Option Exercise | A | 44.23 | 360 | 15,921 | 360 | |
| Nov 02 2017 | CBM | CAMBREX CORP | BROWN GREGORY B | Director | Grant | A | 0.00 | 265 | 0 | 265 | 0 to 265 |
| May 18 2017 | NBS | Caladrius Bioscien ... | BROWN GREGORY B | Director | Grant | A | 0.00 | 2,565 | 0 | 6,715 | 4.2 K to 6.7 K (+61.81 %) |
| Jan 31 2017 | NBS | Caladrius Bioscien ... | BROWN GREGORY B | Director | Option Exercise | A | 3.54 | 2,750 | 9,735 | 2,750 | |
| Jan 31 2017 | NBS | Caladrius Bioscien ... | BROWN GREGORY B | Director | Grant | A | 0.00 | 1,650 | 0 | 4,150 | 2.5 K to 4.2 K (+66.00 %) |
| Oct 12 2016 | NBS | Caladrius Bioscien ... | BROWN GREGORY B | Director | Option Exercise | A | 4.66 | 4,150 | 19,339 | 4,150 | |
| Oct 12 2016 | NBS | Caladrius Bioscien ... | BROWN GREGORY B | Director | Grant | A | 0.00 | 2,500 | 0 | 2,500 | 0 to 2.5 K |
| Jun 13 2008 | GENE | OSCIENT PHARMACEUT ... | BROWN GREGORY B | Director | Option Exercise | A | 1.77 | 750 | 1,328 | 750 | |
| Jun 13 2008 | GENE | OSCIENT PHARMACEUT ... | BROWN GREGORY B | Director | Grant | A | 0.00 | 300 | 0 | 1,200 | 900 to 1.2 K (+33.33 %) |
| Jun 08 2007 | GENE | OSCIENT PHARMACEUT ... | BROWN GREGORY B | Director | Option Exercise | A | 4.91 | 750 | 3,683 | 750 | |
| Jun 08 2007 | GENE | OSCIENT PHARMACEUT ... | BROWN GREGORY B | Director | Grant | A | 0.00 | 300 | 0 | 900 | 600 to 900 (+50.00 %) |
| Aug 22 2006 | GENE | OSCIENT PHARMACEUT ... | BROWN GREGORY B | Director | Option Exercise | A | 1.24 | 12,000 | 14,880 | 12,000 | |
| Aug 22 2006 | GENE | OSCIENT PHARMACEUT ... | BROWN GREGORY B | Director | Grant | A | 0.00 | 4,800 | 0 | 4,800 | 0 to 4.8 K |
Page: 1